Katovich M J, Sninsky C A
Life Sci. 1987 Sep 21;41(12):1529-37. doi: 10.1016/0024-3205(87)90719-3.
We evaluated the tail-skin temperature response to administration of several doses of isoproterenol in streptozotocin-induced diabetic rats after 48 h and after 4 weeks of diabetes. Blood glucose concentrations were significantly increased over controls 48 hours after administration of streptozotocin (65 mg/kg, i.v.) and remained elevated to a similar degree in the 4-week group. Basal rectal temperature and tail-skin temperature (TST) were not different between controls and the diabetic groups and were not affected by administration of saline. However, administration of isoproterenol (25 micrograms/kg, s.c.) caused a significant rise in TST in the control group, but not in the rats diabetic for 4 weeks. A similar but exaggerated response was observed in the controls after subcutaneous administration of 40 micrograms/kg and 100 micrograms/kg of isoproterenol. The TST response in the 4-week diabetic rats still remained negligible with the two higher doses of isoproterenol. When the data were summarized as area under the TST curve, a dose-dependent increase was observed in the control groups and a significant absence of response was observed in the 4-week group. The rats studied 48 h after streptozotocin injection had a similar TST response to the control group after administration of 40 micrograms/kg of isoproterenol. Colonic temperatures did not significantly change between the two groups in any of the studies, although the colonic temperatures tended to rise in the control groups following administration of isoproterenol. We conclude from this study that the absence of a tail-skin temperature response in rats diabetic for 4 weeks results from either a reduced beta-adrenergic receptor mediated response or an altered neural thermoregulatory reflex response, or both. These changes are probably not due to streptozotocin treatment or increases in blood glucose.
我们评估了链脲佐菌素诱导的糖尿病大鼠在糖尿病48小时和4周后,给予不同剂量异丙肾上腺素后尾皮温度的反应。链脲佐菌素(65mg/kg,静脉注射)给药48小时后,血糖浓度较对照组显著升高,且在4周组中维持在相似的升高水平。对照组和糖尿病组的基础直肠温度和尾皮温度(TST)无差异,且不受生理盐水给药的影响。然而,给予异丙肾上腺素(25μg/kg,皮下注射)后,对照组的TST显著升高,但糖尿病4周的大鼠则无此变化。皮下给予40μg/kg和100μg/kg异丙肾上腺素后,对照组出现了类似但更明显的反应。给予两种较高剂量异丙肾上腺素时,4周糖尿病大鼠的TST反应仍然可以忽略不计。当将数据总结为TST曲线下面积时,对照组呈现剂量依赖性增加,而4周组则无明显反应。链脲佐菌素注射48小时后研究的大鼠,在给予40μg/kg异丙肾上腺素后,TST反应与对照组相似。在任何研究中,两组的结肠温度均无显著变化,尽管异丙肾上腺素给药后对照组的结肠温度有升高趋势。我们从这项研究得出结论,糖尿病4周的大鼠尾皮温度反应缺失,是由于β-肾上腺素能受体介导的反应减弱或神经体温调节反射反应改变,或两者兼而有之。这些变化可能不是由于链脲佐菌素治疗或血糖升高所致。